1. Home
  2. QNCX vs JVSA Comparison

QNCX vs JVSA Comparison

Compare QNCX & JVSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • JVSA
  • Stock Information
  • Founded
  • QNCX 2012
  • JVSA 2021
  • Country
  • QNCX United States
  • JVSA Hong Kong
  • Employees
  • QNCX N/A
  • JVSA N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • JVSA
  • Sector
  • QNCX Health Care
  • JVSA
  • Exchange
  • QNCX Nasdaq
  • JVSA NYSE
  • Market Cap
  • QNCX 92.3M
  • JVSA 80.7M
  • IPO Year
  • QNCX 2019
  • JVSA 2024
  • Fundamental
  • Price
  • QNCX $1.60
  • JVSA $10.58
  • Analyst Decision
  • QNCX Strong Buy
  • JVSA
  • Analyst Count
  • QNCX 4
  • JVSA 0
  • Target Price
  • QNCX $9.50
  • JVSA N/A
  • AVG Volume (30 Days)
  • QNCX 147.1K
  • JVSA 18.3K
  • Earning Date
  • QNCX 11-13-2024
  • JVSA 01-01-0001
  • Dividend Yield
  • QNCX N/A
  • JVSA N/A
  • EPS Growth
  • QNCX N/A
  • JVSA N/A
  • EPS
  • QNCX N/A
  • JVSA 0.24
  • Revenue
  • QNCX N/A
  • JVSA N/A
  • Revenue This Year
  • QNCX N/A
  • JVSA N/A
  • Revenue Next Year
  • QNCX N/A
  • JVSA N/A
  • P/E Ratio
  • QNCX N/A
  • JVSA $43.77
  • Revenue Growth
  • QNCX N/A
  • JVSA N/A
  • 52 Week Low
  • QNCX $0.51
  • JVSA $10.02
  • 52 Week High
  • QNCX $2.45
  • JVSA $10.58
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 42.75
  • JVSA N/A
  • Support Level
  • QNCX $1.40
  • JVSA N/A
  • Resistance Level
  • QNCX $1.79
  • JVSA N/A
  • Average True Range (ATR)
  • QNCX 0.15
  • JVSA 0.00
  • MACD
  • QNCX -0.02
  • JVSA 0.00
  • Stochastic Oscillator
  • QNCX 32.79
  • JVSA 0.00

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.

About JVSA JVSPAC ACQUISITION CORP

JVSPAC Acquisition Corp is blank check company.

Share on Social Networks: